4.4 Review Book Chapter

Genomic Data Sharing for Novel Mendelian Disease Gene Discovery: The Matchmaker Exchange

Journal

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-genom-083118-014915

Keywords

Matchmaker Exchange; candidate genes; genomic matchmaking; data sharing; gene discovery; rare diseases

Funding

  1. National Human Genome Research Institute [U54HG006542, UM1HG008900, R01HG009141, U41HG006834, UM1HG006493, U24HG008956]
  2. National Heart, Lung, and Blood Institute [UM1HG006493, U24HG008956]
  3. National Institutes of Health Office of the Director [S10OD021553, R24OD011883]
  4. Genome Canada (CAN-SHARE)
  5. Canadian Institutes of Health Research
  6. RD-Connect (European Union Seventh Framework Programme) [305444]
  7. Solve-RD (European Union Horizon 2020) [779257]
  8. European Joint Programme on Rare Diseases (European Union Horizon 2020) [825575]
  9. BigMed
  10. Norwegian Research Council
  11. Wellcome [206194]

Ask authors/readers for more resources

In the last decade, exome and/or genome sequencing has become a common test in the diagnosis of individuals with features of a rare Mendelian disorder. Despite its success, this test leaves the majority of tested individuals undiagnosed. This review describes the Matchmaker Exchange (MME), a federated network established to facilitate the solving of undiagnosed rare-disease cases through data sharing. MME supports genomic matchmaking, the act of connecting two or more parties looking for cases with similar phenotypes and variants in the same candidate genes. An application programming interface currently connects six matchmaker nodes-the Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources (DECIPHER), GeneMatcher, PhenomeCentral, seqr, MyGene2, and the Initiative on Rare and Undiagnosed Diseases (IRUD) Exchange-resulting in a collective data set spanning more than 150,000 cases from more than 11,000 contributors in 88 countries. Here, we describe the successes and challenges of MME, its individual matchmaking nodes, plans for growing the network, and considerations for future directions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available